Cures Within Reach’s mission is to leverage the speed, safety and cost-effectiveness of repurposing, testing already approved therapies for new diseases: driving more treatments to more patients more quickly.
Our focus: providing seed funds for proof-of-concept or pivotal studies that, when successful, allow a catalytic effect of follow-on funding for trials that build clinical evidence for regulatory approval or for off-label use.
Upcoming Events
Virtual Event: Best Practices in Engaging Community Health Organizations in Clinical Trials
October 28, 2024 at 5:30pm ET: a dialogue on the value of community health organizations to support screening and enrollment opportunities for active clinical trials with sites nearby, especially for clinical researchers, clinical research teams and related institution efforts
Our 2023 Annual Report is available here.
Read about our newest success story in tuberculosis and our new organizational records achieved during 2023:
- $16 million in follow-on funding raised by our researchers
- 16 clinical trials started
- 10 clinical trials completed
Read our January 2024 news release announcing our newest success story in tuberculosis, our new funding partner for LMICs and the 4 LMIC-based clinical trials selected in 2023.
Learn about our 2024 initiatives:
in Pediatrics
for Veterans/Military
and for Underrepresented Patients and Researchers.
Diseases Researched
Repurposing Trials Funded
Institutions Funded
Success Stories
Startups with CWR Investments
Companies Commercializing CWR Projects
Millions of Dollars in Clinical Trial Funding
